Choosing Intraocular Lenses in Patients Undergoing Bilateral Cataract Extraction-One Size Does Not Fit All
Tianjing Li1, Richard S Davidson2, Gianni Virgili3
1Department of Ophthalmology, School of Medicine, Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora.
JAMA Ophthalmology
|September 22, 2022
Summary
No abstract available in PubMed .
Related Concept Videos
Angle Closure Glaucoma: Treatment
628
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
628
Glaucoma: Overview
702
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
702
Open Angle Glaucoma: Treatment
527
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
527


